During the recent session, TNF Pharmaceuticals Inc (NASDAQ:TNFA)’s traded shares were 0.81 million, with the beta value of the company hitting 2.28. At the last check today, the stock’s price was $0.58, reflecting an intraday gain of 9.06% or $0.05. The 52-week high for the TNFA share is $4.34, that puts it down -648.28 from that peak though still a striking 17.24% gain since the share price plummeted to a 52-week low of $0.48. The company’s market capitalization is $1.59M, and the average intraday trading volume over the past 10 days was 0.57 million shares, and the average trade volume was 322.89K shares over the past three months.

TNF Pharmaceuticals Inc (NASDAQ:TNFA) trade information

TNF Pharmaceuticals Inc (TNFA) registered a 9.06% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 9.06% in intraday trading to $0.58, hitting a weekly high. The stock’s 5-day price performance is -3.54%, and it has moved by -60.95% in 30 days. Based on these gigs, the overall price performance for the year is -86.39%. The short interest in TNF Pharmaceuticals Inc (NASDAQ:TNFA) is 0.27 million shares and it means that shorts have 6.39 day(s) to cover.

TNFA Dividends

TNF Pharmaceuticals Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

TNF Pharmaceuticals Inc (NASDAQ:TNFA)’s Major holders

Also, the Mutual Funds coming in first place with the largest holdings of TNF Pharmaceuticals Inc (TNFA) shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. Data provided on Sep 30, 2024 indicates that Vanguard Extended Market Index Fund owns about 13.69 shares. This amounts to just over 0.50 percent of the company’s overall shares, with a $7753.0 market value. The same data shows that the other fund manager holds slightly less at 11.43, or about 0.41% of the stock, which is worth about $6471.0.